戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in diabetic patients in the wake of a prior hypoglycemic episode.
2  risk of CV events within 60 days after each hypoglycemic episode.
3 information or are not related to entering a hypoglycemic episode.
4 ine U100 in reducing the rate of symptomatic hypoglycemic episodes.
5 change in body weight, and rate of confirmed hypoglycemic episodes.
6 red glucose levels and frequent asymptomatic hypoglycemic episodes.
7 ions often result in adverse weight gain and hypoglycemic episodes.
8 ted in a reduced rate of overall symptomatic hypoglycemic episodes.
9  41), or 3 or more (3+; n = 17) prior severe hypoglycemic episodes.
10 isodes of diabetic ketoacidosis and frequent hypoglycemic episodes.
11  near-normal glycemic control without severe hypoglycemic episodes.
12 ction of anion gap and ketone clearance, and hypoglycemic episodes.
13 ng persons treated with insulin, will reduce hypoglycemic episodes.
14 ld contribute to arrhythmias during clinical hypoglycemic episodes.
15 es with the number and severity of postnatal hypoglycemic episodes.
16 ty of life, stage 3 acute kidney injury, and hypoglycemic episodes.
17 issions, 721 (6.1%) of which had one or more hypoglycemic episodes.
18 mg per deciliter in weeks 48 through 52, and hypoglycemic episodes.
19 ed dapagliflozin groups had a higher rate of hypoglycemic episodes (56.6% vs. 51.8%), events suggesti
20  in the insulin group, there was only 1 mild hypoglycemic episode (6%) in the metformin group, P < 0.
21 a and insulin therapies at the time of their hypoglycemic episode (6677 episodes [48.1%]), followed b
22 ved mean glycemic levels, with less frequent hypoglycemic episodes, among both adults and adolescents
23 he vitamin C group, one patient had a severe hypoglycemic episode and another had a serious anaphylax
24               Associations between the first hypoglycemic episode and subsequent CV events and betwee
25 owest blood glucose concentration, number of hypoglycemic episodes and events, and negative interstit
26                                        Fewer hypoglycemic episodes and less weight gain occurred in p
27 trations that were correlated with postnatal hypoglycemic episodes and lower BG levels; these results
28 ss for 2 diabetes-related outcomes (reducing hypoglycemic episodes and preventing ophthalmologic comp
29 s included the rate of nocturnal symptomatic hypoglycemic episodes and proportion of patients with se
30 ispro improves postprandial control, reduces hypoglycemic episodes, and improves patient convenience,
31 ercent of all recipients were free of severe hypoglycemic episodes at 1 year.
32 ere positively correlated with the number of hypoglycemic episodes (BG concentration of 30-45 mg/dL)
33                                 Infants with hypoglycemic episodes (blood glucose concentration <47 m
34 ly if it was much more effective at reducing hypoglycemic episodes compared with their current monito
35                                              Hypoglycemic episodes correlate with injury severity and
36                                     Neonatal hypoglycemic episode, defined as at least 1 consecutive
37 t did reduce the total number of symptomatic hypoglycemic episodes detected by the patients from 49 t
38         Group C (three patients with fasting hypoglycemic episodes) displayed very low rates of insul
39 reatment interventions, and the avoidance of hypoglycemic episodes during insulin therapy remain inco
40 od glucose-confirmed (<56 mg/dL) symptomatic hypoglycemic episodes during the maintenance period.
41 3.77 to -2.64],P < .001) and fewer confirmed hypoglycemic episodes (episodes/patient-year exposure, 2
42 gree than blood glucose during a more severe hypoglycemic episode, falling to 10 +/- 1.2% of blood le
43                                              Hypoglycemic episodes (from baseline to weeks 52 and 83)
44 odes were recorded, with moderate and severe hypoglycemic episodes grouped together.
45                    Patients with one or more hypoglycemic episodes had longer hospitalization, as wel
46  and reduces weight without increasing major hypoglycemic episodes in patients with inadequately cont
47 benefit was defined as a time range of fewer hypoglycemic episodes in the observation period than at
48                                Whether minor hypoglycemic episodes increase risk of dementia is unkno
49  who were stratified according the number of hypoglycemic episodes (&lt; 60 mg/dL glucose) they experien
50                     The occurrence of severe hypoglycemic episodes observed for patients in the Diabe
51                                 Three severe hypoglycemic episodes occurred during the closed-loop ph
52                        Fewer and less severe hypoglycemic episodes occurred in the traditional-thresh
53  monitoring technologies alert a user when a hypoglycemic episode or other blood glucose excursion is
54 llitus (T1DM) experience, on average, 2 to 3 hypoglycemic episodes per week.
55 n (yes or no) in the 100 days after a severe hypoglycemic episode requiring an ED visit or hospitaliz
56                             Of 106 293 total hypoglycemic episodes requiring hospital attention, 69 0
57 e, everolimus, corticosteroids): score 0, no hypoglycemic episodes; score 1, hypoglycemic events requ
58 oints were the rate of nocturnal symptomatic hypoglycemic episodes (severe or blood glucose confirmed
59 nd point was the rate of overall symptomatic hypoglycemic episodes (severe or blood glucose confirmed
60 ur patients with fasting and/or postprandial hypoglycemic episodes) showed qualitatively normal respo
61 e transplant recipients have had a hyper- or hypoglycemic episode since PIT and no complications have
62 ed to quantify the severity and frequency of hypoglycemic episodes under background antihypoglycemic
63 ts with type 2 diabetes, a history of severe hypoglycemic episodes was associated with a greater risk
64 ing to the time of occurrence, the number of hypoglycemic episodes was less with insulin lispro than
65               No difference in the number of hypoglycemic episodes was observed.
66         Group B (three patients with fasting hypoglycemic episodes) was mainly characterized by large
67 3.33]), and the proportions of patients with hypoglycemic episodes were 22.5% vs 31.6% (difference, -
68 2.85]), and the proportions of patients with hypoglycemic episodes were 9.7% vs 14.7% (difference, -5
69 roke, hospitalization for HF) and subsequent hypoglycemic episodes were assessed using multivariable
70 e (< 4.0 mmol/L) and severe (</= 2.2 mmol/L) hypoglycemic episodes were recorded, with moderate and s
71 H glucose levels during the first and fourth hypoglycemic episodes were similar.
72 coefficient of variation of BG, and previous hypoglycemic episodes were the strongest predictors.
73 he counterregulatory responses to subsequent hypoglycemic episodes, which can be prevented by normali